Logo image of ALVAP.PA

KUMULUS VAPE (ALVAP.PA) Stock Fundamental Analysis

EPA:ALVAP - FR0013419876 - Common Stock

4.98 EUR
+0.04 (+0.81%)
Last: 8/25/2025, 7:00:00 PM
Fundamental Rating

6

ALVAP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 52 industry peers in the Specialty Retail industry. While ALVAP has a great health rating, its profitability is only average at the moment. ALVAP has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year ALVAP was profitable.
In the past year ALVAP has reported a negative cash flow from operations.
In the past 5 years ALVAP has always been profitable.
In the past 5 years ALVAP reported 4 times negative operating cash flow.
ALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

The Return On Assets of ALVAP (9.80%) is better than 92.31% of its industry peers.
ALVAP's Return On Equity of 16.03% is amongst the best of the industry. ALVAP outperforms 84.62% of its industry peers.
ALVAP's Return On Invested Capital of 12.75% is amongst the best of the industry. ALVAP outperforms 86.54% of its industry peers.
ALVAP had an Average Return On Invested Capital over the past 3 years of 13.64%. This is above the industry average of 9.18%.
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROIC 12.75%
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ALVAP.PA Yearly ROA, ROE, ROICALVAP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 4.35%, ALVAP is in the better half of the industry, outperforming 78.85% of the companies in the same industry.
ALVAP's Profit Margin has improved in the last couple of years.
ALVAP's Operating Margin of 5.90% is fine compared to the rest of the industry. ALVAP outperforms 76.92% of its industry peers.
In the last couple of years the Operating Margin of ALVAP has grown nicely.
ALVAP has a Gross Margin of 23.53%. This is in the lower half of the industry: ALVAP underperforms 71.15% of its industry peers.
In the last couple of years the Gross Margin of ALVAP has remained more or less at the same level.
Industry RankSector Rank
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
ALVAP.PA Yearly Profit, Operating, Gross MarginsALVAP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

7

2. Health

2.1 Basic Checks

ALVAP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALVAP has about the same amout of shares outstanding than it did 1 year ago.
ALVAP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ALVAP has an improved debt to assets ratio.
ALVAP.PA Yearly Shares OutstandingALVAP.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALVAP.PA Yearly Total Debt VS Total AssetsALVAP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 4.71 indicates that ALVAP is not in any danger for bankruptcy at the moment.
ALVAP has a Altman-Z score of 4.71. This is amongst the best in the industry. ALVAP outperforms 94.23% of its industry peers.
ALVAP has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.21, ALVAP belongs to the best of the industry, outperforming 86.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 4.71
ROIC/WACC1.85
WACC6.9%
ALVAP.PA Yearly LT Debt VS Equity VS FCFALVAP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

ALVAP has a Current Ratio of 3.30. This indicates that ALVAP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.30, ALVAP belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
ALVAP has a Quick Ratio of 1.76. This is a normal value and indicates that ALVAP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.76, ALVAP belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 1.76
ALVAP.PA Yearly Current Assets VS Current LiabilitesALVAP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

3

3. Growth

3.1 Past

ALVAP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.18%.
The Earnings Per Share has been growing by 97.48% on average over the past years. This is a very strong growth
ALVAP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.12%.
Measured over the past years, ALVAP shows a very strong growth in Revenue. The Revenue has been growing by 41.89% on average per year.
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%

3.2 Future

ALVAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.43% yearly.
The Revenue is expected to decrease by -0.11% on average over the next years.
EPS Next Y-13.94%
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALVAP.PA Yearly Revenue VS EstimatesALVAP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALVAP.PA Yearly EPS VS EstimatesALVAP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.15 indicates a rather cheap valuation of ALVAP.
Compared to the rest of the industry, the Price/Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 98.08% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, ALVAP is valued rather cheaply.
A Price/Forward Earnings ratio of 6.81 indicates a rather cheap valuation of ALVAP.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 90.38% of the companies listed in the same industry.
ALVAP is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.15
Fwd PE 6.81
ALVAP.PA Price Earnings VS Forward Price EarningsALVAP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALVAP indicates a rather cheap valuation: ALVAP is cheaper than 92.31% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.28
ALVAP.PA Per share dataALVAP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The decent profitability rating of ALVAP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%

6

5. Dividend

5.1 Amount

ALVAP has a Yearly Dividend Yield of 3.68%.
ALVAP's Dividend Yield is rather good when compared to the industry average which is at 2.95. ALVAP pays more dividend than 92.31% of the companies in the same industry.
ALVAP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years2
ALVAP.PA Yearly Dividends per shareALVAP.PA Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

17.39% of the earnings are spent on dividend by ALVAP. This is a low number and sustainable payout ratio.
DP17.39%
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%
ALVAP.PA Yearly Income VS Free CF VS DividendALVAP.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 2M -2M 4M
ALVAP.PA Dividend Payout.ALVAP.PA Dividend Payout, showing the Payout Ratio.ALVAP.PA Dividend Payout.PayoutRetained Earnings

KUMULUS VAPE

EPA:ALVAP (8/25/2025, 7:00:00 PM)

4.98

+0.04 (+0.81%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners36.98%
Ins Owner ChangeN/A
Market Cap15.29M
Analysts86
Price Target7.91 (58.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP17.39%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.49%
PT rev (3m)-10.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-16.47%
EPS NY rev (3m)-16.47%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-7.69%
Revenue NY rev (3m)-7.69%
Valuation
Industry RankSector Rank
PE 6.15
Fwd PE 6.81
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 0.93
P/tB 1.14
EV/EBITDA 3.28
EPS(TTM)0.81
EY16.27%
EPS(NY)0.73
Fwd EY14.68%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS19.77
BVpS5.37
TBVpS4.36
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 9.8%
ROE 16.03%
ROCE 17.84%
ROIC 12.75%
ROICexc 17.69%
ROICexgc 22.5%
OM 5.9%
PM (TTM) 4.35%
GM 23.53%
FCFM N/A
ROA(3y)9.89%
ROA(5y)10.27%
ROE(3y)16.02%
ROE(5y)15.99%
ROIC(3y)13.64%
ROIC(5y)14.38%
ROICexc(3y)17.75%
ROICexc(5y)21.73%
ROICexgc(3y)22.02%
ROICexgc(5y)24.77%
ROCE(3y)19.12%
ROCE(5y)20.26%
ROICexcg growth 3Y1.55%
ROICexcg growth 5Y9.12%
ROICexc growth 3Y-5.62%
ROICexc growth 5Y6.22%
OM growth 3Y0.64%
OM growth 5Y19.19%
PM growth 3Y4.02%
PM growth 5Y42.75%
GM growth 3Y5.68%
GM growth 5Y0.12%
F-Score3
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA 0.82
Cap/Depr 57.64%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 1.76
Altman-Z 4.71
F-Score3
WACC6.9%
ROIC/WACC1.85
Cap/Depr(3y)181.05%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21.18%
EPS 3Y20.5%
EPS 5Y97.48%
EPS Q2Q%-23.21%
EPS Next Y-13.94%
EPS Next 2Y-5.29%
EPS Next 3Y-1.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.12%
Revenue growth 3Y20.74%
Revenue growth 5Y41.89%
Sales Q2Q%-51.16%
Revenue Next Year-6.25%
Revenue Next 2Y-0.99%
Revenue Next 3Y-0.11%
Revenue Next 5YN/A
EBIT growth 1Y-24.16%
EBIT growth 3Y21.51%
EBIT growth 5Y69.12%
EBIT Next Year20.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-124.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.39%
OCF growth 3YN/A
OCF growth 5YN/A